CompletedNCT01111734
N-acetylcysteine for self-harm in adolescents
About this title
Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in Adolescents
Read the official source — NCT01111734Medication studyAges 13–21United StatesSuicide prevention
Understand this study
Who was this study for?
Listed age limits: 13 years to 21 years.
What did participation involve?
The protocol includes: Having magnetic resonance imaging (MRI) scans.
- Listed locations
- MinneapolisSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateMarch 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 67
- Sponsor
- University of Minnesota
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Dietary supplement, Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 13 Years to 21 Years
- Official registry ID
- NCT01111734
- Official title
Show the full official title
N-Acetylcysteine in the Treatment of Deliberate Self-Harm in Adolescents: An Open Label Pilot Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Minneapolis
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Minnesota, a university.
Did this study involve medication?
Yes. The study involved medication, including fMRI.
Who was this study for?
Listed age limits: 13 years to 21 years.
